Lannett

Lannett is a Pennsylvania-based pharmaceutical company that manufactures and commercializes drugs for the treatment of generic diseases. Read more

Timothy C. Crew's photo - CEO of Lannett

CEO

Timothy C. Crew

CEO Approval Rating

70/100

Founded:

1942

Status:

PublicIndependent CompanyNYSELCI

LANNETT TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

TEVA is Lannett's #1 rival. TEVA is a Public company that was founded in Petach Tikva, Center District in 1901. Like Lannett, TEVA also works within the Pharmaceuticals field. TEVA has 39,196 more employees vs. Lannett.

Amneal is perceived as one of Lannett's biggest rivals. Amneal was founded in 2002, and is headquartered in Bridgewater, New Jersey. Like Lannett, Amneal also operates in the Pharmaceuticals sector. Amneal generates $1.5B more revenue vs. Lannett.

Akorn is a top competitor of Lannett. Akorn is a Private company that was founded in 1971 in Lake Forest, Illinois. Like Lannett, Akorn also operates in the Pharmaceuticals space. Compared to Lannett, Akorn has 1,207 more employees.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Sandoz a competitor of Lannett?

Lannett Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$510.7M

Lannett's revenue is the ranked 12th among it's top 10 competitors. The top 10 competitors average 20.6B. Over the last four quarters, Lannett's revenue has decreased by 18.5%. Specifically, in Q1 2021's revenue was $112.4M; in Q4 2020, it was $133.9M; in Q3 2020, it was $126.5M; in Q2 2020, Lannett's revenue was $137.9M.

Lannett Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Kremers Urban Pharmaceuticals Inc.

Sep 2015

Source »
$1.2B
Kremers Urban develops and commercializes pharmaceutical products.

These are all the companies that Lannett has acquired. Lannett's latest acquisition was Kremers Urban Pharmaceuticals Inc. in Sep 2015. Kremers Urban develops and commercializes pharmaceutical products.

Lannett Funding History

Since Lannett was founded in 1942, it has participated in 8 rounds of funding. In total Lannett has raised $1.1B. Lannett's last funding round was on Apr 2021 for a total of $190.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Apr 2021
$190M
-
Private Placement
Apr 2021
$350M
-
Private Placement
Sep 2019
$86.3M
-
Debt
May 2019
$30.5M
-
Debt
Mar 2019
$24.2M
-

Since Lannett was founded in 1942, it has participated in 8 rounds of funding. In total Lannett has raised $1.1B. Lannett's last funding round was on Apr 2021 for a total of $190.0M

Lannett Investments

No recent investments found related to Lannett

These are all the companies that Lannett has invested in. Lannett's latest investment was Kremers Urban Pharmaceuticals Inc. in Sep 2015. Kremers Urban develops and commercializes pharmaceutical products.

Lannett News

May 4, 2021Global Legal Chronicle

Lannett Company's $585 Million Comprehensive Refinancing

Debevoise & Plimpton LLP advised Lannett Company on the deal. Lannett Company, Inc. executed its $585... See more »
April 29, 2021BioSpace

Lannett To Report Fiscal 2021 Third-Quarter Financial Results, Host Conference Call On Wednesday, May 5

Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fisca... See more »
April 22, 2021BioSpace

Lannett Announces Closing Of $350 Million Senior Secured Notes And $190 Million Second Lien Senior Secured Loan Facility

Lannett Company, Inc. (NYSE: LCI) today announced the closing of the $350 million aggregate principal... See more »
April 9, 2021MarketScreener

Announces Pricing Of $350 Million Senior Secured Notes Due 2026

(marketscreener.com) PHILADELPHIA, April 9, 2021 /PRNewswire/ -- Lannett Company, Inc. today announce... See more »
April 6, 2021Markets Insider

Lannett Company, Inc. -- Moody's rates Lannett's proposed secured notes B1; B3 CFR affirmed

Rating Action: Moody's rates Lannett's proposed secured notes B1; B3 CFR affirmedRead the full articl... See more »
April 3, 2021Pharmabiz

Lannett's partner Respirent Pharma seeks US FDA approval for generic Advair Diskus

Lannett Company, Inc. announced the submission of an Abbreviated New Drug Application (ANDA) for flut... See more »

Lannett Press Releases

February 8, 2021PR Newswire

Lannett Begins Marketing Chlorpromazine Hydrochloride Tablets

PHILADELPHIA, Feb. 8, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it ... See more »
March 9, 2020centralcharts

Lannett To Present At The 32nd annual Roth Conference On March 16

Lannett To Present At The 32nd annual Roth Conference On March 16 PR Newswire PHILADELPHIA, March 9, ... See more »
July 19, 2019StreetInsider

Shareholder Class Action Against Lannett Company (LCI) Survives Motion to Dismiss; The Law Offices of Timothy L. Miles Encourages Shareholders to Contact the Firm

HENDERSONVILLE, TN / ACCESSWIRE / July 19, 2019 / The Law Offices of Timothy L. Miles, who has been l... See more »
July 3, 2019PR Newswire

FDA Clears Path For The Continuing Review Of Lannett Company's New Drug Application

PHILADELPHIA, July 3, 2019 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today commented on the U... See more »
June 18, 2019PR Newswire

Lannett Launches Aspirin And Extended-Release Dipyridamole Capsules

PHILADELPHIA, June 18, 2019 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it... See more »
May 29, 2019PR Newswire

Lannett Commences Marketing Generic Concerta®

PHILADELPHIA, May 29, 2019 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it ... See more »
May 23, 2019PR Newswire

Lannett Appoints Melissa V. Rewolinski, PhD, To Board Of Directors

PHILADELPHIA, May 23, 2019 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced the appo... See more »

Social Media

Lannett Headquarters

1150 Northbrook Drive Suite 155

Trevose, Pennsylvania19053

215-333-9000

Driving Directions »

Trending Companies

Lannett Summary

ABOUT

Overview

Lannett is a Pennsylvania-based pharmaceutical company that manufactures and commercializes drugs for the treatment of generic diseases. Lannett was founded in 1942. Lannett's headquarters is located in Trevose, Pennsylvania, USA 19053. It has raised...

CEO

Lannett's CEO, Timothy C. Crew, currently has an approval rating of 70%. Lannett's primary competitors are TEVA, Amneal & Akorn.

Frequently Asked Questions about Lannett

  1. When was Lannett founded?

    Lannett was founded in 1942
  2. Who is Lannett's CEO?

    Lannett's CEO is Timothy C. Crew
  3. How much revenue does Lannett generate?

    Lannett generates $510.7M in revenue
  4. How much funding does Lannett have?

    Lannett has historically raised $1.1B in funding
  1. Where is Lannett's headquarters?

    Lannett's headquarters is in Trevose Pennsylvania, USA
  2. How many employees does Lannett have?

    Lannett has 1,020 employees
  3. What sector does Lannett operate in?

    Lannett is in Pharmaceuticals, Biotechnology
  4. Who are Lannett's competitors?

    Lannett's top competitors are TEVA, Amneal, Akorn